Barkley and Associates | PMHNP Comprehensive Examination
Barkley PMHNP Comprehensive Examination
2026/2027 | Verified Questions
Barkley and Associates | PMHNP Comprehensive Examination | Professional Psychiatric-Mental Health
Nurse Practitioner Candidates
350 Verified Questions | 4 Core Domains | Academic Year 2026/2027
Prepared by
Barkley and Associates | PMHNP Comprehensive Examination
Comprehensive Certification Examination Actual Exam | Academic Year 2026/2027
Barkley PMHNP Comprehensive Examination 2026/2027 | Verified Questions
,INTRODUCTION
This collection presents three hundred fifty (350) original, certification-level questions developed for the
PMHNP Comprehensive Examination with Barkley and Associates. The material is organized into four core
domains: Psychopharmacology and Neurobiology with 88 questions; Psychotherapy and Behavioral
Interventions with 88 questions; Diagnostic Reasoning and Psychopathology with 87 questions; and Special
Populations and Professional Role with 87 questions. Every item is written to reinforce the official PMHNP
Comprehensive Certification Examination objectives, supporting actual exam readiness and the development
of clinical proficiency in receptor-level pharmacology, psychotherapy selection, differential diagnosis, and the
care of individuals across the lifespan within professional psychiatric-mental health standards. All content is
aligned to the 2026/2027 academic year and reflects current evidence-based clinical care standards.
ACTUAL QUESTIONS
Domain 1: Psychopharmacology and Neurobiology
Question 1. Which receptor action is most associated with the anxiolytic effect of buspirone?
A. Antagonism at dopamine 2 receptors
B. Agonism at gamma-aminobutyric acid A receptors
C. Blockade of norepinephrine reuptake
D. Partial agonism at serotonin 1A receptors
Correct Answer: D
Rationale: Barkley and Associates PMHNP certification materials and Stahl provide that buspirone is a
partial agonist at the serotonin 1A receptor, which produces anxiolysis without sedation, dependence, or
muscle relaxation. Because it lacks gamma-aminobutyric acid activity, it does not replace a benzodiazepine
acutely during withdrawal.
Question 2. A client reports nausea during the first week of a selective serotonin reuptake
inhibitor. Which receptor mechanism best explains this effect?
A. Blockade of dopamine 2 receptors in the chemoreceptor trigger zone
B. Increased serotonin activity at serotonin 3 receptors in the gastrointestinal tract
C. Antagonism of histamine 1 receptors
D. Inhibition of acetylcholinesterase
Correct Answer: B
Rationale: Per Barkley and Associates PMHNP certification materials and current clinical care standards,
serotonin is largely a gastrointestinal transmitter, and the sudden rise in synaptic serotonin stimulates
serotonin 3 receptors in the gut before downregulation occurs. The effect typically fades, and taking the
medication with food reduces it.
Question 3. Which receptor action is most closely linked to the weight gain seen with
olanzapine and clozapine?
A. Agonism at dopamine 1 receptors
B. Blockade of norepinephrine transporters
C. Partial agonism at serotonin 1A receptors
D. Antagonism at serotonin 2C and histamine 1 receptors
Correct Answer: D
Rationale: Per standard psychiatric-mental health method used in the PMHNP certification materials,
combined histamine 1 and serotonin 2C antagonism increases appetite and alters satiety signaling, which
drives the metabolic effects of these agents. Monitoring weight, glucose, and lipids is part of routine care
for clients receiving them.
Question 4. A client taking haloperidol develops muscle rigidity and tremor. Which pathway
is most implicated?
A. Blockade of dopamine 2 receptors in the mesolimbic pathway
Barkley PMHNP Comprehensive Examination 2026/2027 | Verified Questions
, B. Blockade of dopamine 2 receptors in the mesocortical pathway
C. Blockade of dopamine 2 receptors in the nigrostriatal pathway
D. Blockade of serotonin 2A receptors in the cortex
Correct Answer: C
Rationale: Barkley and Associates PMHNP certification materials and the diagnostic standards indicate
that the nigrostriatal pathway regulates movement, so dopamine blockade there produces parkinsonism.
The mesolimbic pathway relates to positive symptoms, and the mesocortical pathway relates to negative
and cognitive symptoms.
Question 5. Excess dopamine activity in the mesolimbic pathway is most associated with
which clinical feature?
A. Negative symptoms such as flat affect and avolition
B. Extrapyramidal motor symptoms
C. Elevated prolactin with galactorrhea
D. Positive symptoms such as hallucinations and delusions
Correct Answer: D
Rationale: Barkley and Associates PMHNP certification materials and Stahl provide that overactivity in
the mesolimbic pathway is linked to the positive symptoms of psychosis, which is why dopamine 2
antagonism there is the core antipsychotic mechanism. Blockade in other pathways produces the motor,
endocrine, and cognitive adverse effects.
Question 6. A client taking risperidone reports breast tenderness and menstrual changes.
Which mechanism explains this?
A. Dopamine blockade in the tuberoinfundibular pathway removes inhibition of prolactin release
B. Serotonin 2C antagonism alters gonadotropin release
C. Histamine 1 blockade raises prolactin levels
D. Anticholinergic effects delay menstruation
Correct Answer: A
Rationale: Per Barkley and Associates PMHNP certification materials and current clinical care standards,
dopamine normally inhibits prolactin secretion through the tuberoinfundibular pathway, so blockade there
produces hyperprolactinemia. Agents with partial agonism at dopamine 2 receptors carry less risk of this
effect.
Question 7. Aripiprazole is described as a dopamine 2 partial agonist. What is the clinical
significance of this property?
A. It blocks dopamine completely at every dose
B. It has no meaningful effect on dopamine signaling
C. It lowers dopamine transmission where dopamine is excessive and raises it where dopamine is low
D. It raises dopamine in the nigrostriatal pathway only
Correct Answer: C
Rationale: Per standard psychiatric-mental health method used in the PMHNP certification materials,
partial agonism acts as a stabilizer, reducing signaling in overactive mesolimbic circuits while preserving
enough dopamine activity to limit extrapyramidal effects and prolactin elevation. Akathisia can still occur
because of partial agonism at other receptors.
Question 8. Which mechanism best explains the rapid antidepressant effect of ketamine?
A. Blockade of serotonin reuptake
B. Inhibition of monoamine oxidase
C. Agonism at gamma-aminobutyric acid A receptors
D. Antagonism at N-methyl-D-aspartate glutamate receptors with a downstream increase in synaptic
plasticity
Correct Answer: D
Barkley PMHNP Comprehensive Examination 2026/2027 | Verified Questions
, Rationale: Barkley and Associates PMHNP certification materials and the diagnostic standards indicate
that n-methyl-D-aspartate antagonism produces a glutamate surge and downstream signaling that
restores synaptic connections, producing benefit within hours rather than weeks. This mechanism is
distinct from monoamine reuptake inhibition used in most oral antidepressants.
Question 9. Why is abrupt discontinuation of a long-standing benzodiazepine dangerous?
A. The medication accumulates into a toxic metabolite
B. Loss of gamma-aminobutyric acid A mediated inhibition can produce rebound anxiety, seizures, and
autonomic instability
C. The liver loses the ability to metabolize the medication
D. Serotonin levels fall abruptly
Correct Answer: B
Rationale: Barkley and Associates PMHNP certification materials and Stahl provide that chronic exposure
leads to receptor adaptation, and sudden removal leaves the client with unopposed central nervous system
excitation. A gradual taper reduces the risk of withdrawal seizures.
Question 10. A client reports dizziness on standing after starting quetiapine. Which receptor
action explains this?
A. Antagonism at dopamine 2 receptors
B. Inhibition of serotonin reuptake
C. Antagonism at alpha 1 adrenergic receptors
D. Agonism at serotonin 1A receptors
Correct Answer: C
Rationale: Per Barkley and Associates PMHNP certification materials and current clinical care standards,
alpha 1 blockade produces vasodilation and orthostatic hypotension, especially during initial titration.
Slow titration, bedtime dosing, and fall precautions reduce the risk in older adults.
Question 11. A client on a tricyclic antidepressant reports dry mouth, constipation, and
blurred vision. Which receptor action is responsible?
A. Blockade of dopamine 2 receptors
B. Antagonism at muscarinic acetylcholine receptors
C. Agonism at serotonin 2A receptors
D. Inhibition of gamma-aminobutyric acid transaminase
Correct Answer: B
Rationale: Per standard psychiatric-mental health method used in the PMHNP certification materials,
muscarinic blockade produces the classic anticholinergic cluster and, in older adults, can cause confusion,
urinary retention, and falls. Agents with low anticholinergic burden are preferred in late life.
Question 12. Which statement distinguishes monoamine oxidase A from monoamine oxidase
B?
A. Monoamine oxidase A metabolizes dopamine only, while monoamine oxidase B metabolizes
serotonin
B. Both enzymes metabolize only tyramine
C. Neither enzyme is present in the central nervous system
D. Monoamine oxidase A metabolizes serotonin and norepinephrine, while monoamine oxidase B
preferentially metabolizes dopamine
Correct Answer: D
Rationale: Barkley and Associates PMHNP certification materials and the diagnostic standards indicate
that this distinction explains dietary tyramine risk with nonselective inhibitors and the different roles of
selective monoamine oxidase B inhibitors in Parkinson disease. Nonselective agents require dietary
restrictions because gut monoamine oxidase A normally inactivates tyramine.
Question 13. Which neurotransmitter transporter is the primary target of atomoxetine?
Barkley PMHNP Comprehensive Examination 2026/2027 | Verified Questions
Barkley PMHNP Comprehensive Examination
2026/2027 | Verified Questions
Barkley and Associates | PMHNP Comprehensive Examination | Professional Psychiatric-Mental Health
Nurse Practitioner Candidates
350 Verified Questions | 4 Core Domains | Academic Year 2026/2027
Prepared by
Barkley and Associates | PMHNP Comprehensive Examination
Comprehensive Certification Examination Actual Exam | Academic Year 2026/2027
Barkley PMHNP Comprehensive Examination 2026/2027 | Verified Questions
,INTRODUCTION
This collection presents three hundred fifty (350) original, certification-level questions developed for the
PMHNP Comprehensive Examination with Barkley and Associates. The material is organized into four core
domains: Psychopharmacology and Neurobiology with 88 questions; Psychotherapy and Behavioral
Interventions with 88 questions; Diagnostic Reasoning and Psychopathology with 87 questions; and Special
Populations and Professional Role with 87 questions. Every item is written to reinforce the official PMHNP
Comprehensive Certification Examination objectives, supporting actual exam readiness and the development
of clinical proficiency in receptor-level pharmacology, psychotherapy selection, differential diagnosis, and the
care of individuals across the lifespan within professional psychiatric-mental health standards. All content is
aligned to the 2026/2027 academic year and reflects current evidence-based clinical care standards.
ACTUAL QUESTIONS
Domain 1: Psychopharmacology and Neurobiology
Question 1. Which receptor action is most associated with the anxiolytic effect of buspirone?
A. Antagonism at dopamine 2 receptors
B. Agonism at gamma-aminobutyric acid A receptors
C. Blockade of norepinephrine reuptake
D. Partial agonism at serotonin 1A receptors
Correct Answer: D
Rationale: Barkley and Associates PMHNP certification materials and Stahl provide that buspirone is a
partial agonist at the serotonin 1A receptor, which produces anxiolysis without sedation, dependence, or
muscle relaxation. Because it lacks gamma-aminobutyric acid activity, it does not replace a benzodiazepine
acutely during withdrawal.
Question 2. A client reports nausea during the first week of a selective serotonin reuptake
inhibitor. Which receptor mechanism best explains this effect?
A. Blockade of dopamine 2 receptors in the chemoreceptor trigger zone
B. Increased serotonin activity at serotonin 3 receptors in the gastrointestinal tract
C. Antagonism of histamine 1 receptors
D. Inhibition of acetylcholinesterase
Correct Answer: B
Rationale: Per Barkley and Associates PMHNP certification materials and current clinical care standards,
serotonin is largely a gastrointestinal transmitter, and the sudden rise in synaptic serotonin stimulates
serotonin 3 receptors in the gut before downregulation occurs. The effect typically fades, and taking the
medication with food reduces it.
Question 3. Which receptor action is most closely linked to the weight gain seen with
olanzapine and clozapine?
A. Agonism at dopamine 1 receptors
B. Blockade of norepinephrine transporters
C. Partial agonism at serotonin 1A receptors
D. Antagonism at serotonin 2C and histamine 1 receptors
Correct Answer: D
Rationale: Per standard psychiatric-mental health method used in the PMHNP certification materials,
combined histamine 1 and serotonin 2C antagonism increases appetite and alters satiety signaling, which
drives the metabolic effects of these agents. Monitoring weight, glucose, and lipids is part of routine care
for clients receiving them.
Question 4. A client taking haloperidol develops muscle rigidity and tremor. Which pathway
is most implicated?
A. Blockade of dopamine 2 receptors in the mesolimbic pathway
Barkley PMHNP Comprehensive Examination 2026/2027 | Verified Questions
, B. Blockade of dopamine 2 receptors in the mesocortical pathway
C. Blockade of dopamine 2 receptors in the nigrostriatal pathway
D. Blockade of serotonin 2A receptors in the cortex
Correct Answer: C
Rationale: Barkley and Associates PMHNP certification materials and the diagnostic standards indicate
that the nigrostriatal pathway regulates movement, so dopamine blockade there produces parkinsonism.
The mesolimbic pathway relates to positive symptoms, and the mesocortical pathway relates to negative
and cognitive symptoms.
Question 5. Excess dopamine activity in the mesolimbic pathway is most associated with
which clinical feature?
A. Negative symptoms such as flat affect and avolition
B. Extrapyramidal motor symptoms
C. Elevated prolactin with galactorrhea
D. Positive symptoms such as hallucinations and delusions
Correct Answer: D
Rationale: Barkley and Associates PMHNP certification materials and Stahl provide that overactivity in
the mesolimbic pathway is linked to the positive symptoms of psychosis, which is why dopamine 2
antagonism there is the core antipsychotic mechanism. Blockade in other pathways produces the motor,
endocrine, and cognitive adverse effects.
Question 6. A client taking risperidone reports breast tenderness and menstrual changes.
Which mechanism explains this?
A. Dopamine blockade in the tuberoinfundibular pathway removes inhibition of prolactin release
B. Serotonin 2C antagonism alters gonadotropin release
C. Histamine 1 blockade raises prolactin levels
D. Anticholinergic effects delay menstruation
Correct Answer: A
Rationale: Per Barkley and Associates PMHNP certification materials and current clinical care standards,
dopamine normally inhibits prolactin secretion through the tuberoinfundibular pathway, so blockade there
produces hyperprolactinemia. Agents with partial agonism at dopamine 2 receptors carry less risk of this
effect.
Question 7. Aripiprazole is described as a dopamine 2 partial agonist. What is the clinical
significance of this property?
A. It blocks dopamine completely at every dose
B. It has no meaningful effect on dopamine signaling
C. It lowers dopamine transmission where dopamine is excessive and raises it where dopamine is low
D. It raises dopamine in the nigrostriatal pathway only
Correct Answer: C
Rationale: Per standard psychiatric-mental health method used in the PMHNP certification materials,
partial agonism acts as a stabilizer, reducing signaling in overactive mesolimbic circuits while preserving
enough dopamine activity to limit extrapyramidal effects and prolactin elevation. Akathisia can still occur
because of partial agonism at other receptors.
Question 8. Which mechanism best explains the rapid antidepressant effect of ketamine?
A. Blockade of serotonin reuptake
B. Inhibition of monoamine oxidase
C. Agonism at gamma-aminobutyric acid A receptors
D. Antagonism at N-methyl-D-aspartate glutamate receptors with a downstream increase in synaptic
plasticity
Correct Answer: D
Barkley PMHNP Comprehensive Examination 2026/2027 | Verified Questions
, Rationale: Barkley and Associates PMHNP certification materials and the diagnostic standards indicate
that n-methyl-D-aspartate antagonism produces a glutamate surge and downstream signaling that
restores synaptic connections, producing benefit within hours rather than weeks. This mechanism is
distinct from monoamine reuptake inhibition used in most oral antidepressants.
Question 9. Why is abrupt discontinuation of a long-standing benzodiazepine dangerous?
A. The medication accumulates into a toxic metabolite
B. Loss of gamma-aminobutyric acid A mediated inhibition can produce rebound anxiety, seizures, and
autonomic instability
C. The liver loses the ability to metabolize the medication
D. Serotonin levels fall abruptly
Correct Answer: B
Rationale: Barkley and Associates PMHNP certification materials and Stahl provide that chronic exposure
leads to receptor adaptation, and sudden removal leaves the client with unopposed central nervous system
excitation. A gradual taper reduces the risk of withdrawal seizures.
Question 10. A client reports dizziness on standing after starting quetiapine. Which receptor
action explains this?
A. Antagonism at dopamine 2 receptors
B. Inhibition of serotonin reuptake
C. Antagonism at alpha 1 adrenergic receptors
D. Agonism at serotonin 1A receptors
Correct Answer: C
Rationale: Per Barkley and Associates PMHNP certification materials and current clinical care standards,
alpha 1 blockade produces vasodilation and orthostatic hypotension, especially during initial titration.
Slow titration, bedtime dosing, and fall precautions reduce the risk in older adults.
Question 11. A client on a tricyclic antidepressant reports dry mouth, constipation, and
blurred vision. Which receptor action is responsible?
A. Blockade of dopamine 2 receptors
B. Antagonism at muscarinic acetylcholine receptors
C. Agonism at serotonin 2A receptors
D. Inhibition of gamma-aminobutyric acid transaminase
Correct Answer: B
Rationale: Per standard psychiatric-mental health method used in the PMHNP certification materials,
muscarinic blockade produces the classic anticholinergic cluster and, in older adults, can cause confusion,
urinary retention, and falls. Agents with low anticholinergic burden are preferred in late life.
Question 12. Which statement distinguishes monoamine oxidase A from monoamine oxidase
B?
A. Monoamine oxidase A metabolizes dopamine only, while monoamine oxidase B metabolizes
serotonin
B. Both enzymes metabolize only tyramine
C. Neither enzyme is present in the central nervous system
D. Monoamine oxidase A metabolizes serotonin and norepinephrine, while monoamine oxidase B
preferentially metabolizes dopamine
Correct Answer: D
Rationale: Barkley and Associates PMHNP certification materials and the diagnostic standards indicate
that this distinction explains dietary tyramine risk with nonselective inhibitors and the different roles of
selective monoamine oxidase B inhibitors in Parkinson disease. Nonselective agents require dietary
restrictions because gut monoamine oxidase A normally inactivates tyramine.
Question 13. Which neurotransmitter transporter is the primary target of atomoxetine?
Barkley PMHNP Comprehensive Examination 2026/2027 | Verified Questions
